Latest News and Press Releases
Want to stay updated on the latest news?
-
Sanofi fait le point sur le programme clinique consacré au venglustat PARIS – Le 1er juin 2021 – Une étude pivot de phase II/III consacrée au venglustat dans le traitement de la polykystose...
-
Sanofi provides update on venglustat clinical program PARIS – JUNE 1, 2021 – A pivotal Phase 2/3 study of venglustat in autosomal dominant polycystic kidney disease (ADPKD) did not meet...
-
SOCIETE DES BAINS DE MER ET DU CERCLE DES ETRANGERS A MONACO Société anonyme monégasque au capital de 24 516 661€. Siège social : Monte-Carlo - Place du Casino,...
-
All First Quarter 2021 comparisons are made versus the First Quarter 2019 On a GAAP basis, total sales increased 35%, net income was $171 million, and diluted EPS increased 118% to $2.51Comparable...
-
IRVINE, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer, and manufacturer of differentiated transcatheter aortic valve implantation (TAVI) systems (also referred to as...
-
Sanofi to showcase data from its transformative oncology pipeline at 2021 ASCO Meeting Early clinical data for investigational oral selective estrogen receptor (SERD), amcenestrant, show potential...
-
San Francisco, May 19, 2021 (GLOBE NEWSWIRE) -- LucidLink, an innovator in cloud file technology, announced it raised $12 million in Series A funding to support accelerated growth and continue to...
-
BOSTON, May 17, 2021 (GLOBE NEWSWIRE) -- HYCU, Inc., a pioneering enterprise software company specializing in multi-cloud data backup and recovery as a service, today announced Rajh Das has joined...
-
Les données d’un essai pivot présentées au Congrès 2021 de l’ATS montrent que Dupixent® (dupilumab) réduit significativement les crises d’asthme chez l’enfant et améliore sa fonction...
-
Pivotal data at ATS 2021 show Dupixent® (dupilumab) significantly reduced asthma attacks and improved lung function in children Dupixent is the only biologic medicine to improve lung function...